Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project

Published On 2025-09-10 14:26 GMT   |   Update On 2025-09-10 14:26 GMT
Advertisement

Ahmedabad: Torrent Pharmaceuticals Limited announced that it has entered into a Share Subscription and Shareholders' Agreement (SSSA) to acquire a 26 percent equity stake in Torrent Urja 27 Private Limited, a step-down Subsidiary of the Company’s holding Company. The Transaction is being carried out at arm’s length basis.

Torrent Urja, currently a wholly owned subsidiary of Torrent Green Energy Private Limited, is a special purpose vehicle formed for setting up captive power project in Gujarat.
Advertisement
The investment, valued at Rs 7.92 crore for 79,19,340 Class A equity shares at a face value of Rs 10 each, is intended to enhance the share of renewable power sources in the operation of the Company and to comply with regulatory requirement for being a captive user under Indian electricity laws, Torrent stated in a BSE filing.
Torrent Urja, incorporated in India and registered with the Registrar of Companies, Gujarat at Ahmedabad on 06-Aug-24
, has not yet commenced operations. The acquisition is expected to be completed within 18–20 months.

Torrent Pharmaceuticals, headquartered in Ahmedabad, Gujarat, is a prominent Indian pharmaceutical company known for developing, manufacturing, and marketing branded and generic medications. It operates across various therapeutic areas, including cardiovascular, central nervous system, and diabetes care, with a strong presence in both regulated and emerging global markets.

Read also: Torrent Pharma seeks CCI clearance to acquire majority stake in JB Pharma in Rs 19500 crore deal



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News